[Hub]/) : Traits : Trunk fat-free mass : ← →

chr12:14,220,891-15,743,444

Best TWAS P=3.09e-13 · Best GWAS P=1.62e-11 conditioned to 0.0335

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
1	CommonMind	Brain Pre-frontal Cortex	C12orf60	0.28	0.25	lasso	4	0.24	2.0e-29	5.8	6.5	1.0e-10	-0.49	0.29	0.71	FALSE
2	GTEx	Adipose Visceral Omentum	WBP11	0.15	0.11	lasso	4	0.12	8.7e-07	-5.5	5.4	8.6e-08	-0.32	0.26	0.24	FALSE
3	GTEx	Artery Tibial	WBP11	0.09	0.06	lasso	2	0.06	3.8e-05	-6.0	6.3	2.7e-10	-0.48	0.19	0.80	FALSE
4	GTEx	Brain Caudate basal ganglia	C12orf60	0.39	0.34	lasso	3	0.32	5.4e-10	5.8	5.9	3.4e-09	-0.37	0.29	0.70	FALSE
5	GTEx	Brain Cerebellum	C12orf60	0.19	0.17	lasso	3	0.13	1.2e-04	5.8	5.6	2.2e-08	-0.35	0.14	0.26	FALSE
6	GTEx	Brain Cortex	C12orf60	0.44	0.28	lasso	3	0.29	1.2e-08	5.9	6.4	1.3e-10	-0.42	0.19	0.76	FALSE
7	GTEx	Brain Hypothalamus	C12orf60	0.28	0.27	lasso	4	0.19	3.8e-05	5.8	5.8	6.4e-09	-0.36	0.16	0.39	FALSE
8	GTEx	Brain Nucleus accumbens basal ganglia	RP11-174G6.5	0.23	0.13	lasso	4	0.11	8.9e-04	-6.4	6.3	2.8e-10	-0.48	0.08	0.63	FALSE
9	GTEx	Brain Putamen basal ganglia	C12orf60	0.33	0.32	lasso	3	0.29	1.5e-07	5.9	6.0	1.6e-09	-0.37	0.17	0.60	FALSE
10	GTEx	Breast Mammary Tissue (Female)	C12orf60	0.19	0.17	lasso	3	0.12	2.6e-04	5.8	5.9	3.9e-09	-0.36	0.10	0.41	FALSE
11	GTEx	Cells Transformed fibroblasts	C12orf60	0.10	0.10	lasso	2	0.09	1.8e-07	5.2	5.8	8.4e-09	-0.36	0.39	0.60	FALSE
12	GTEx	Heart Left Ventricle	C12orf60	0.24	0.23	lasso	5	0.26	7.1e-14	5.8	6.1	9.3e-10	-0.42	0.30	0.70	FALSE
13	GTEx	Heart Left Ventricle	H2AFJ	0.16	0.07	lasso	8	0.05	1.1e-03	-6.3	-6.3	3.8e-10	0.85	0.04	0.96	FALSE
14	GTEx	Liver	H2AFJ	0.18	0.11	lasso	8	0.04	2.7e-02	-6.3	-5.4	5.9e-08	0.79	0.05	0.67	FALSE
15	GTEx	Muscle Skeletal	WBP11	0.08	0.08	lasso	5	0.08	2.4e-08	-5.5	5.6	1.9e-08	-0.45	0.46	0.53	FALSE
16	GTEx	Muscle Skeletal	C12orf60	0.23	0.10	lasso	4	0.12	1.1e-11	5.9	5.6	2.6e-08	-0.26	0.27	0.73	FALSE
17	GTEx	Nerve Tibial	WBP11	0.11	0.10	lasso	3	0.09	1.0e-06	-6.0	5.4	6.8e-08	-0.42	0.21	0.78	FALSE
18	GTEx	Nerve Tibial	C12orf60	0.39	0.27	enet	11	0.30	9.6e-22	5.8	5.8	8.8e-09	-0.37	0.30	0.70	FALSE
19	GTEx	Skin Not Sun Exposed Suprapubic	C12orf60	0.15	0.16	lasso	2	0.13	1.6e-07	5.9	5.9	3.1e-09	-0.36	0.31	0.68	FALSE
20	GTEx	Skin Sun Exposed Lower leg	C12orf60	0.09	0.06	enet	11	0.05	4.0e-05	5.8	6.1	1.1e-09	-0.44	0.32	0.66	FALSE
21	GTEx	Thyroid	C12orf60	0.16	0.10	enet	9	0.12	8.1e-10	5.2	6.3	3.3e-10	-0.37	0.48	0.52	FALSE
22	METSIM	Adipose	C12orf60	0.14	0.10	lasso	4	0.08	1.2e-12	5.8	5.8	7.1e-09	-0.37	0.27	0.73	FALSE
23	METSIM	Adipose	MGP	0.04	0.04	bslmm	359	0.04	6.2e-07	-4.2	5.7	1.5e-08	-0.37	0.97	0.03	FALSE
24	ROSMAP	Brain Pre-frontal Cortex	WBP11	0.10	0.05	lasso	4	0.06	1.2e-08	-6.0	7.3	3.1e-13	-0.72	0.07	0.93	TRUE
25	ROSMAP	Brain Pre-frontal Cortex	C12orf60	0.26	0.29	lasso	5	0.29	1.9e-37	5.9	5.8	7.2e-09	-0.33	0.24	0.76	FALSE
26	YFS	Blood	H2AFJ	0.05	0.02	bslmm	360	0.03	2.9e-10	-6.3	-6.4	1.3e-10	0.68	0.03	0.97	FALSE
27	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	C12orf60	0.17	0.03	blup	56	0.07	2.9e-06	5.2	5.8	7.5e-09	-0.63	0.05	0.85	FALSE
28	The Cancer Genome Atlas	Breast Invasive Carcinoma	C12orf60	0.05	0.04	enet	4	0.04	7.3e-09	5.9	5.5	4.8e-08	-0.29	0.24	0.76	FALSE
29	The Cancer Genome Atlas	Esophageal Carcinoma	ERP27	0.10	0.12	blup	75	0.08	1.5e-03	-4.7	5.2	1.7e-07	-0.21	0.03	0.84	FALSE
30	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	C12orf60	0.10	0.04	enet	7	0.05	2.0e-06	-4.9	5.8	8.5e-09	-0.49	0.23	0.60	FALSE
31	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	C12orf60	0.07	0.08	lasso	3	0.07	1.1e-08	5.9	5.4	6.7e-08	-0.27	0.24	0.76	FALSE
32	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	C12orf60	0.12	0.07	enet	8	0.07	5.4e-05	5.9	6.7	1.5e-11	-0.64	0.06	0.86	FALSE
33	The Cancer Genome Atlas	Brain Lower Grade Glioma	C12orf60	0.14	0.14	lasso	4	0.13	2.2e-14	5.9	6.3	3.4e-10	-0.43	0.24	0.76	FALSE
34	The Cancer Genome Atlas	Brain Lower Grade Glioma	WBP11	0.03	0.03	blup	57	0.02	2.3e-03	-6.3	6.8	1.5e-11	-0.90	0.01	0.93	FALSE
35	The Cancer Genome Atlas	Lung Adenocarcinoma	C12orf60	0.07	0.05	enet	7	0.05	1.5e-06	5.9	6.2	6.9e-10	-0.42	0.25	0.75	FALSE
36	The Cancer Genome Atlas	Lung Adenocarcinoma	ERP27	0.15	0.28	lasso	6	0.28	8.3e-33	-5.1	5.1	2.9e-07	-0.23	0.02	0.98	FALSE
37	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	C12orf60	0.05	0.05	lasso	3	0.04	1.1e-05	5.9	6.2	6.8e-10	-0.43	0.23	0.76	FALSE
38	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	ERP27	0.17	0.24	enet	13	0.25	6.7e-28	-4.9	5.1	3.0e-07	-0.27	0.02	0.97	FALSE
39	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	C12orf60	0.10	0.01	blup	56	0.07	1.6e-05	5.2	6.3	3.7e-10	-0.49	0.08	0.20	FALSE
40	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	ERP27	0.14	0.12	lasso	5	0.11	2.9e-05	-5.1	5.1	3.1e-07	-0.23	0.02	0.96	FALSE
41	The Cancer Genome Atlas	Prostate Adenocarcinoma	C12orf60	0.05	0.03	lasso	1	0.01	1.2e-02	5.9	5.9	2.8e-09	-0.36	0.08	0.29	FALSE
42	The Cancer Genome Atlas	Skin Cutaneous Melanoma	ERP27	0.13	0.02	blup	74	0.06	1.4e-02	-5.0	5.3	1.4e-07	-0.20	0.02	0.71	FALSE
43	The Cancer Genome Atlas	Thyroid Carcinoma	C12orf60	0.16	0.16	enet	10	0.18	1.3e-17	5.9	7.0	2.0e-12	-0.61	0.25	0.75	FALSE